Quest Diagnostics Inc DGX
News
Quest Diagnostics Declares Quarterly Cash Dividend
Workforce Drug Test Cheating Surged in 2023, Finds Quest Diagnostics Drug Testing Index Analysis of Nearly 10 Million Drug Tests
Lab Week 2024 - Javarus Smith
Helping To Change Perceptions of Bloodwork by Being ‘Phenomenal’
Quest Diagnostics to Speak at the 2024 Leerink Partners Healthcare Crossroads Conference
Quest Diagnostics Names Murali Balakumar Senior Vice President and Chief Information and Digital Officer
Quest Supports Expansion of Community Center and Provides No-Cost Wellness Testing to Newark Faith Community
Quest Diagnostics to Acquire PathAI Diagnostics to Accelerate AI and Digital Pathology Adoption in Cancer Diagnosis; Forms Licensing Agreements with PathAI
Quest Diagnostics Foundation and Green Bronx Machine Expand Collaboration to Bring Acclaimed Indoor Gardening Curriculum to More Communities and Raise Awareness for Impact of Nutrition Education on Health Equity
Quest Diagnostics Reports First Quarter 2024 Financial Results; Raises Guidance for Full Year 2024
Quest Diagnostics Adds p-tau217 Blood Biomarker Testing to Suite of Services Designed to Assess Risk and Help Aid Diagnosis of Alzheimer's Disease
Q4HE Initiative Recognized for Efforts To Reduce Health Disparities
My Quest Story - Jessica Clow
Quest Diagnostics and Broad Clinical Labs to Evaluate Whole Genome Sequencing as First-Line Genetic Test for Developmental Delay
My Quest Story - Pauline Chaves
She Is Not Skipping a Beat, and Patients Are Noticing
Study in Frontiers in Neurology Affirms Amyloid Blood Test Can Help Identify Patients Who May Forgo Imaging Evaluation for Alzheimer's Disease
My Quest Story - Eddy Hurst
Quest Diagnostics to Release First Quarter 2024 Financial Results on April 23, 2024